Aemetis (AMTX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Revenue grew 27% year-over-year to $54.6 million, driven by gains in all operating segments and the first-time recognition of Section 45Z production tax credits.
Gross profit reached $2.8 million, reversing a $5.1 million loss in the prior year, mainly due to lower corn costs, increased biodiesel sales, and tax credit income.
Operating loss improved by over 60% to $6.3 million from $15.6 million year-over-year.
Net loss narrowed to $21.7 million from $24.5 million year-over-year, reflecting improved gross profit and lower SG&A expenses as a percentage of revenue.
Adjusted EBITDA improved to negative $1.3 million from negative $10.7 million in Q1 2025.
Financial highlights
Dairy RNG sales volume increased 55% to 110,000 MMBtu; India Biodiesel revenue rebounded to $10.5 million.
Section 45Z Production Tax Credits contributed $4.0 million in Q1 2026.
SG&A expenses decreased by $1.4 million to $9.1 million, now 17% of revenue.
Cash and equivalents stood at $4.8 million at quarter-end, flat versus year-end 2025.
Total debt increased to $404.7 million.
Outlook and guidance
Focus for 2026 includes scaling production, monetizing renewable fuel credits, completing the India IPO, and refinancing debt.
Key catalysts: updated 45ZCF-GREET model, MVR commissioning, rising LCFS prices, and India IPO progress.
Substantial doubt remains about ability to continue as a going concern due to high debt and negative cash flow.
Latest events from Aemetis
- Proxy seeks votes on director election and auditor ratification, with emphasis on governance and compensation.AMTX
Proxy filing7 Apr 2026 - Dairy RNG output soared, losses narrowed, and investments and policy wins set up 2026 growth.AMTX
Q4 202512 Mar 2026 - Q2 revenue up 48% to $66.6M, but net loss widened and liquidity concerns persist.AMTX
Q2 20242 Feb 2026 - Board approves executive bonuses, $80M share buyback, and charter amendments for share structure.AMTX
Proxy Filing28 Jan 2026 - Q3 2024 revenue up 19% to $81.4M, but net loss and liquidity risks remain.AMTX
Q3 202414 Jan 2026 - Stockholders to vote on key changes to capital structure and meeting procedures, with Board support.AMTX
Proxy Filing31 Dec 2025 - Revenue up 43% to $268M, but net loss widened; policy and tax credits to drive future growth.AMTX
Q4 202426 Dec 2025 - Votes sought to amend capital structure and empower Board for future growth and flexibility.AMTX
Proxy Filing19 Dec 2025 - Up to $234 million in securities may be offered amid ongoing losses and risk disclosures.AMTX
Registration Filing16 Dec 2025